Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Vincerx Pharma, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 35 | 34 | −1 |
| Shares | 12.8M | 12.1M | −748.4K (−5.8%) |
| Value | $13.3M | $15.7M | +$2.36M (+17.7%) |
New holders (2)
Institutions that held Vincerx Pharma, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 135,044 | $175.6K | 0.00% |
| JPMorgan Chase & Co | 394 | $512 | 0.00% |
Sold out (3)
Institutions that held Vincerx Pharma, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Tang Capital Management LLC | 101,762 | $105.8K |
| Susquehanna International Group, LLP | 27,125 | $28.2K |
| Bank of Montreal | 12,400 | $14.1K |